The preliminary public health notification issued by the FDA on July 14, 2005, provides clinicians with current information and guidance concerning the malfunctions of the above-named ICDs. View the notification.

On July 15, 2005, the FDA issued advice for patients with VENTAK PRIZM® 2 DR and CONTAK RENEWAL® ICDs. View the document.